Evidence map›Paper›PMID 18295882›Full record

ArticlePlasmid2008

Construction and use of new cloning vectors for the rapid isolation of recombinant proteins from Escherichia coli.

C J Rocco, K L Dennison, Vadim A Klenchin, I Rayment, J C Escalante-Semerena

Open access · greenAbstract read
In one paragraph

Article in Plasmid, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 124 citations in OpenAlex.

  1. Science advances · 2026
    Article
  2. InJournal of bacteriology · 2026
    Article
  3. InbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. InPathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Mutation ofJournal of bacteriology · 2023
    Article
  10. The coenzyme BMicrobial cell (Graz, Austria) · 2023
    Article
  11. Mutation ofbioRxiv : the preprint server for biology · 2023
    Article
  12. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  13. Article
  14. Genetic Analysis Using Vitamin BJournal of bacteriology · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. NADThe Journal of biological chemistry · 2020
    Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

C J RoccoDepartment of Bacteriology, University of Wisconsin, 1550 Linden Drive, Madison, WI 53706, USA.
K L Dennison
Vadim A Klenchin
I Rayment
J C Escalante-Semerena
University of Wisconsin–Madison · US

Funding

Sirtuins and Metabolic Pathway IntegrationR01GM062203 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ESCALANTE, JORGE C · 2001 to 2017
$4.7M
X-RAY DIFFRACTION STUDIES ON MYOSIN SUBFRAGMENT-1R01AR035186 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI RAYMENT, IVAN · 1986 to 2007
$3.2M
NIAMS NIH HHS AR35186NIAMS NIH HHS R01 AR035186NIGMS NIH HHS GM62203NIGMS NIH HHS R01 GM062203
6 · The paper itself

Abstract

We describe the construction and use of two sets of vectors for the over-expression and purification of protein from Escherichia coli. The set of pTEV plasmids (pTEV3, 4, 5) directs the synthesis of a recombinant protein with a N-terminal hexahistidine (His(6)) tag that is removable by the tobacco etch virus (TEV) protease. The set of pKLD plasmids (pKLD66, 116) directs the synthesis of a recombinant protein that contains a N-terminal His(6) and maltose-binding protein tag in tandem, which can also be removed with TEV protease. The usefulness of these plasmids is illustrated by the rapid, high-yield purification of the 2-methylcitrate dehydratase (PrpD) protein of Salmonella enterica, and the 2-methylaconitate isomerase (PrpF) protein of Shewanella oneidensis, two enzymes involved in the catabolism of propionate to pyruvate via the 2-methylcitric acid cycle.

Indexed as

Genetic TechniquesGenetic VectorsBacterial ProteinsCitratesCloning, MolecularEndopeptidasesEscherichia coliEscherichia coli ProteinsHistidineHydro-LyasesModels, GeneticOligopeptidesPlasmidsRecombinant Fusion ProteinsRecombinant ProteinsSalmonella enterica2-methylcitric acidBacterial ProteinsCitratesEndopeptidasesEscherichia coli ProteinsHis-His-His-His-His-HisHistidineHydro-Lyasesmethylcitrate dehydratase, E coliOligopeptidesRecombinant Fusion ProteinsRecombinant ProteinsTEV protease

Identifiers

PMID18295882
PMCPMC2386272
OpenAlexW2072234490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.